... Among the total group of 155 patients, 22 had oral cavity cancer, 94 patients had oropharyngeal cancer, and 39 patients had hypopharyngeal cancer The distribution of patients based on age, gender, ... (31%) This involved patients (36%) with oral cavity cancer, 34 patients (36%) with oropharyngeal cancer, and patients (18%) with hypopharyngeal cancer There were no significant differ- Regional ... patients with oral cavity cancer would support the use of the RADPLAT protocol as an alternative to the current standard of care for advanced resectable oral cavity cancer: surgery and post-operative...
... ăn sống như vậy. Tôi hỏi cô ta họ có nói ăn để chữa bệnh gì không? Cô ta nói họ nói ăn để chữa cancer thế là tôi bắt chước theo, từ đó mỗi ngày tôi nhai ăn sống. Sáng một muổng canh, chiều một muổng ...
... [14] Lung cancer Twentyman PR [15], WU R [16] Brain cancer Darling JL [17] Ovarian cancer Whelan RDH et al [18], Wilson AP [19] Prostate cancer Harper ME [20], Bright RK et al [21] Breast cancer ... test tumor response to cancer drug therapy Tumor References Colorectal cancer Paraskeva C et al [9], Park J-G et al [10], Whitehead [11] Testicular Cancer Pera MF [12] Skin cancer Parkinson EK et ... O’Hare MJ [22], Speirs V [23] Cervical cancer Stern P et al [24] Bladder cancer Fu VX et al [25] Head and neck cancer Edington KG et al [26] Pancreatic cancer Iguchi H [27] http://www.medsci.org...
... patients with pT1–2 breast cancer Anticancer Res 2004; 24(5): 3221–3224 Stein RC, Zvelebil MJ: The application of 2D gel-based proteomics methods to the study of breast cancer J Mammary Gland Biol ... Cancer Serum Biomarkers Identified by Mass Spectrometry Clinical Chemistry 2005; 51: 2229–2235 22 Jemal A Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, et al Cancer statistics, 2004 CA Cancer ... JAMA 1999;281:1470–2 24 Smith RA, Cokkinides V, Eyre HJ American Cancer Society guidelines for the early detection of cancer, 2004 CA Cancer J Clin 2004; 54:41–52 25 Chan DW, Sell S Tumor markers...
... models of colorectal cancer, breast cancer, and chronic myelogenous and acute lymphoblastic leukaemia J Exp Clin Cancer Res.2005; 24(4):505-14 O'Connell JB, Maggard MA, Ko CY Colon cancer survival ... Committee on Cancer sixth edition staging J Natl Cancer Inst.2004; 96(19):1420-5 Australian Institute of Health and Welfare (AIHW), Australasian Association of Cancer Registries (AACR) Cancer in ... colorectal cancer patients by MALDI-TOF MS We used WCX magnetic beads to screen potential serum biomarkers for colorectal cancer detection A total of 264 serum samples from colorectal cancer patients...
... Candido KA, Cao Z, et al Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancerCancer Res 2005; 65: 5317-5324 Lowery AR, Gobin AM, Day ... cells In vitro cytotoxicity of SLNs carrying 399 anticancer drugs was higher than that of conventional drug formulations [22] 5-FU is an anticancer agent and the most widely used drug in the treatment ... the preparation of SLNs for water soluble anticancer drugs including peptides The SLNs system has a high potential to improve the uptake of anticancer drugs inside colon tumors The release profile...
... role in cancer formation and progression, one may reason that functional single nucleotide polymorphisms in these genes might render the carrier susceptible to cancer, including esophageal cancer ... oesophageal cancer mortality in china Int J Cancer 1993;54:713-719 Hu J, Nyren O, Wolk A, Bergstrom R, Yuen J, Adami HO, Guo L, Li H, Huang G, Xu X, et al.: Risk factors for oesophageal cancer in ... genotype in various cancers.[19] Therefore, it’s reasonable to hypothesize that the p53 Arg72Pro and GSTP1 Ile105Val polymorphisms may functionally related to the risk of esophageal cancer A number...
... from January 2003 through December 2009, a total of 20 women with early-stage invasive uterine cancer underwent vaginal RT with lymphadenectomy in Sapporo Medical University Hospital Among them, ... vaginal approach and is designed to preserve child- bearing potential in young patients with cervical cancer This procedure requires ligation and cutting the descending branches of uterine arteries ... above RT now has become an acceptable treatment modality in patients with early invasive uterine cancer who hope for preservation of fertility However, vaginal RT is completely different from laser...
... by in vitro testing in human cancer cell lines We observed that 198 RGD-M-LCL had increased anti-proliferative activity and increased the induction of apoptosis in cancer cells compared to free ... Institute of Cell Biology, Chinese Academy of Sciences (Shanghai, China) The breast cancer Bcap-37 and colon cancer HT-29 cell lines were maintained in our lab A375 cells and Bcap-37 cells were ... efficacy in vivo of doxorubicin-loaded, long-circulating liposomes modified with cancer- specific monoclonal antibody Clin Cancer Res 2009; 15:1973-80 Lin HY, Lansing L, Merillon JM, et al Integrin...
... Molecular imaging of cancer with positron emission tomography Nat Rev Cancer 2002; 2: 683-93 http://www.medsci.org Int J Med Sci 2010, 25 Yap JT, Carney JP, Hall NC, et al Image-guided cancer therapy ... J, Jenne J, et al CNN-Gd(3+) Enables Cell Nucleus Molecular Imaging of Prostate Cancer Cells: The Last 600 nm Cancer Res 2002; 62: 7018-24 31 Fawell S, Seery J, Daikh Y, et al Tat-mediated delivery ... characterized with laser desorption mass spectrometry (Finnigan, Vision 2000) Cell culture The human breast cancer cell line MDA-MB-231 was obtained from the American Type Culture Collection (ATCC) MDA-MB-231...
... R, Ward E, Murray T, Xu J, and Thun MJ Cancer statistics 2007 CA Cancer J Clin 2007; 57: 43-66 Li Y, and Cozzi PJ Targeting uPA/uPAR in prostate cancerCancer Treat Rev 2007;33(6):521-7 Catalona ... treatment for patients with hormone-refractory prostate cancer: a Minnie Pearl Cancer Research Network phase II trial Clin Genitourin Cancer 2007; 5: 278-283 Di LG, Autorino R, Giuliano M, Morelli ... temozolomide in hormone-refractory prostate cancerCancer Chemother Pharmacol 2000; 45: 509-512 Duesberg P, Li R, Sachs R, Fabarius A, Upender MB, and Hehlmann R Cancer drug resistance: the central role...
... esophagus cancer, stomach cancer, liver cancer, pancreas cancer, lung cancer cancers, and cancers on the minor sites, whereas the equivalence is uncertain for bladder cancer and prostate cancer ... stomach cancer (151, 25.9%), liver cancer (155, 22.7%), lung cancer (162, 27.2%), pancreatic cancer (157, 2.6%), prostate cancer (185, 0.7%), and bladder cancer (188, 1.8%)) We combined the cancers ... adjusted cancer RRs and their CIs had a high degree of overlap (with a small standard error) between the two control groups in deaths from esophagus cancer, stomach cancer, liver cancer, and lung cancer...
... an open system The overall cancer process can be conceptualized as a “system-in-failing,” from a localized cancer representing a subsystem failure, to a metastatic cancer that can be seen as ... being threatened From this perspective, cancer cure would require not just successful cancer therapy of the gross disease, in order to limit the total cancer burden of the system, but also simultaneously ... expenditure, VDR genotype and colon and rectal cancers (United States) Cancer Causes and Control 2004; 15: 863-872 20 Blask D, Dauchy R, and Sauer L Putting cancer to sleep at night: The neuroendocrine/circadian...
... exposure in lung cancerCancer Res 2002; 62: 1377-81 19 Liang G., Xing D, Miao X, et al Sequence variations in the DNA repair gene XPD and risk of lung cancer in a Chinese population Int J Cancer 2003; ... group A and risk of primary lung cancerCancer Epidemiol Biomarkers Prev 2002; 11: 993-7 10 Wu X, Zhao H, Wei Q, et al XPA polymorphism associated with reduced lung cancer risk and a modulating effect ... non-small cell lung cancer Carcinogenesis 2004; 25: 2433-41 12 Vogel U, Overvad K, Wallin H, et al Combinations of polymorphisms in XPD, XPC and XPA in relation to risk of lung 67 cancerCancer Lett...
... weight loss relies on the reported a-amylase-inhibiting activity of the Phaseolus vulgaris extract [15-19] Phaseolus vulgaris extract has been shown in vitro to inhibit the activity of a-amylase ... formula containing Phaseolus vulgaris extract as the major ingredient produced significant decreases in body fat while essentially maintaining lean body mass Phaseolus vulgaris extract appears to ... black bean (Phaseolus vulgaris) J Food Biochem 1984; 1:385-401 Gibbs B, Alli I Characterization of a purified alpha-amylase inhibitor from white kidney bean (Phaseolus vulgaris) Food Research...
... breast cancers However, it is noticed that these data were obtained by using noncancerous and genetically naïve BRCA1/2-/- ES cells, BRCA2-/- V-C8 hamster cells, and two BRCA2-proficient breast cancer ... inhibition observed between BRCA mutant cancer cells and pre-cancerous cells [36] Figure Effect of a potent PARP-1 inhibitor, AG14361, on BRCA1 mutant and control cancer cells (A) Clonogenic survival ... BRCA related breast cancer Clearly, a common finding among above studies is that BRCA-/- pre-cancerous cells are very sensitive to PARP inhibition than wild type cells while cancer cells exhibit...
... Parking DM, Laara E, Muri CS, et al Estimates of the world wide frequency of sixteen major cancers in 1980 Int J Cancer 1988; 41: 184 12 Poletti ME, Goncalves OD, Mazzaro I Measurements of X-ray scatter ... the result, this method could be adapted for use in mammography for the early detection of breast cancer There were no significant differences in peak position, peak height or area between diffraction ... Towns-Andrews E, Slawson S, Evan A, Pinder SE, Ellis IO, Boggis CRM, Hufton AP and Dance DR Breast cancer diagnosis using scattered X-rays J Synchrotron Rad 2000; 7: 348-352 Malden CH, Speller RD,...
... human cancers including non small cell lung cancer [22], bladder cancer, breast cancer and glioblastoma multiforme Increased expression of EGFR is reported in 40-80% of non small cell lung cancer ... of breast cancer, prostrate cancer and small cell lung cancer [27] Elevated IGF-I R autophosphorylation and kinase activity has been reported in breast cancer [28] Elevated prostrate cancer risk ... Conforma Inc - Thyroid cancer BC Phase I Phase I Phase I [83] [84] BC- Breast cancer, LC- Lung cancer, NSCLC- Non small cell lung cancer, SSC- squamous cell carcinoma, CRColorectal cancer, CML- Chronic...